fashion -WSS

fashion

author：fashion 2025-09-30 17:02:52 - browse：3888

Colorful broken DNA helix genome. -- health coverage from STAT — Adobe

In 2020, as biotech stocks surged amid the pandemic, a startup called Taysha Gene Therapies raised over $300 million off an audacious promise: It was going to license and develop gene therapies for at least 18 different rare and serious neurological diseases.

The effort brought hope for many rare disease families, some of whom had raised money to fund the UT-Southwestern scientist who designed the treatments after they saw no other options for their children.

Last week, the grand plan took perhaps a final blow. Taysha announced it would discontinue development of a treatment for giant axonal neuropathy, or GAN, a fatal, degenerative disease known to affect fewer than 100 people worldwide. The FDA, Taysha said, had requested an additional clinical trial that would be infeasible.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How to save PrEP access — and even expand it
Next article： Clinicians often fail to acknowledge the pain caused by long Covid

hotspot

WSS

Israel demolishes home of alleged Palestinian attacker, fueling West Bank tensions

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Hospitals need to get ahead of regulations on climate change

Bursting ice dam in Alaska highlights risks of glacial flooding around the globe

focus

fashion

explore

After affirmative action ruling, medical educators look to 'holistic review'

J&J reports mixed data on next

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Boeing's 1st astronaut flight bumped into next year, more repairs needed

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Lawsuit challenges CMS nursing home minimum staffing rule

In Memoriam: Notable people who died in 2023

Medical students need to learn the potent medicine of empathy

Activists slam private health insurers over coverage restrictions

The world needs the new pandemic treaty

leisure time

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

Ozempic cut risk of death in diabetes patients with chronic kidney disease

Arizona Democrat to raise extreme heat with Biden 1 year out from Senate primary

NYC plans to house migrants on an island in the East River

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Beyond aggravation: Constipation is an American epidemic

focus

hotspot

Wikipedia

explore